A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients-Reference-Cited by-同舟云学术

A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients

Published:2008-04 Issue:4 Volume:19 Page:769-773
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Zinzani P.L.,Tani M.,Fanti S.,Stefoni V.,Musuraca G.,Castellucci P.,Marchi E.,Farsad M.,Fina M.,Pellegrini C.,Alinari L.,Derenzini E.,de Vivo A.,Bacci F.,Pileri S.,Baccarani M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/4/769/582800/mdm560.pdf

Reference22 articles.

1. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma;Fisher;N Engl J Med,1993

2. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience;Dixon;J Clin Oncol,1986

3. CHOP plus rituximab with CHOP chemotherapy in elderly patients with diffuse large B-cell lymphoma. A Groupe d'Etude des Lymphomes de l'Adulte study;Coiffier;N Engl J Med,2002

4. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia;Sehn;J Clin Oncol,2005

5. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte;Feugier;J Clin Oncol,2005

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioligand Therapy in Lymphoma;PET Clinics;2024-10

2. Radioimmunotherapy;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. Radionuclide Therapies and Correlative Imaging;Radiology‐Nuclear Medicine Diagnostic Imaging;2023-03-10

4. Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab;Cancers;2022-04-10

5. 90Y-ibritumomab tiuxetan in B-cell non-Hodgkin lymphomas: Real-world data from the United Arab Emirates;Advances in Radiation Oncology;2021-12